Bio-Rad Laboratories
BIO
$278.21
Share price
-2.48%
Change (1 day)
-39.76%
Change (1 year)
Categories
Bio-Rad Laboratories, Inc. is an American manufacturer of products for the life science research and clinical diagnostics markets.
Bio-Rad Laboratories (BIO) - Net assets
Net assets on the balance sheet as of December 2023 : $8.74 B
According to Bio-Rad Laboratories's latest financial reports the company has $8.74 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Bio-Rad Laboratories - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $8.74 B | -9.09% |
| 2022-12-31 | $9.61 B | -29.74% |
| 2021-12-31 | $13.68 B | 38.52% |
| 2020-12-31 | $9.87 B | 71.67% |
| 2019-12-31 | $5.75 B | 43.15% |
| 2018-12-31 | $4.02 B | 37.2% |
| 2017-12-31 | $2.93 B | 13.61% |
| 2016-12-31 | $2.57 B | 3.56% |
| 2015-12-31 | $2.49 B | 13.97% |
| 2014-12-31 | $2.18 B | -0.07% |
| 2013-12-31 | $2.18 B | 8.49% |
| 2012-12-31 | $2.01 B | 15.54% |
| 2011-12-31 | $1.74 B | 13.23% |
| 2010-12-31 | $1.54 B | 20.43% |
| 2009-12-31 | $1.27 B | 19.48% |
| 2008-12-31 | $1.07 B | 10.18% |
| 2007-12-31 | $0.97 B | 18.57% |
| 2006-12-31 | $0.81 B | 24.55% |
| 2005-12-31 | $0.65 B | 10.23% |
| 2004-12-31 | $0.59 B | 20.39% |
| 2003-12-31 | $0.49 B | 29.42% |
| 2002-12-31 | $0.38 B | 34.95% |
| 2001-12-31 | $0.28 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | 686.79% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | $46.84 B | 435.88% | 🇺🇸 USA |
 Agilent Technologies A | $6.18 B | -29.21% | 🇺🇸 USA |
 Becton Dickinson BDX | $25.33 B | 189.81% | 🇺🇸 USA |
 General Electric GE | $28.58 B | 226.96% | 🇺🇸 USA |
 Danaher DHR | $53.49 B | 511.93% | 🇺🇸 USA |
 PerkinElmer
PKI | $8.03 B | -8.09% | 🇺🇸 USA |